Scheme Rating
IME Scheme Rating
The Scheme does not meet our selection criteria at this time
Not a recommended fund: This is not a recommended fund, primarily because the AMC does not meet our selection criteria. We believe that there are better fund houses to invest in, within the Indian fund universe.
IME Strategy Rating
Small & Mid Cap Focused: The portfolio focuses on the companies in small & midcap space which have high earnings growth, with emphasis on good earnings quality available at a reasonable valuation. The key tenet of the fund is ‘Share prices are slaves of earnings growth.
PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).
IME View on Edelweiss PMS Focused Mid/Smallcap
Trailing Performance
1yr | 3yr | 5yr | Since Inception | |
---|---|---|---|---|
Edelweiss PMS Focused Mid/Smallcap | 24.6 | 12.1 | 25.1 | 12 |
S&P BSE 500 TRI | 41.1 | 18.4 | 22.4 | 14.2 |
Alpha over Broad Mkt BM | -16.5 | -6.3 | 2.7 | -2.2 |
Nifty Smallcap 250 | 50.5 | 25.3 | 31.2 | |
Alpha over Category BM | -25.9 | -13.2 | -6.1 |
Performance as of: 30-Sep-24 | Inception Date: 03-Aug-15
Fund Managers
Sahil Shah | 3-star rated FM
CIO | 18 yrs Experience | 0 yrs at current firm
Past Experience: Edelweiss Research (Analyst), Anagram Capital (Analyst)
Sahil Shah has over 17 years of extensive experience, he has worked as an analyst and managed mutual funds and PMS. Previously, he worked with Edelweiss Small Cap Fund (AUM 3300cr) as a fund manager and was also co-fund manager for Midcap and Multicap funds at Edelweiss. Prior to joining Edelweiss Asset Management, he has worked with Edelweiss Financial Services and Anagram Capital
Fee Structure
Fee Structure | Fee |
---|---|
Fixed Fee Structure | 2.5 |
Variable Fee Structures | 1.5% fixed + 20% above no hurdle |
Exit Fees | 1yr(2%), 2yr(1%), 3yr(0.75%) |
AMC
AMC: Edelweiss PMS (click link for detailed AMC review)
Not a top recommendation due to being an MF-driven PMS: Edelweiss has not succeeded in scaling up its investment capabilities on the equity fund management side, to the same level it has built up its other business units. We would wait for their AUM to scale and investment team to stabilise & mature prior to recommending investments.
Edelweiss PMS does not meet our criteria for PMS AMC Selection at this time. Understand our AMC rating criteria at AMC Rating Criteria or contact us via the LiveChat to learn more.
Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.